NLM Logo

N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide MeSH Supplementary Concept Data 2024


MeSH Supplementary
N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide
Unique ID
C550549
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C550549
Entry Term(s)
PF 03814735
PF-03814735
PF03814735
Registry Number
0
Heading Mapped to
*Heterocyclic Compounds, 3-Ring
*Pyrimidines
Frequency
6
Note
an aurora kinase inhibitor and antineoplastic agent; structure in first source
Source
Mol Cancer Ther 2010 Apr;9(4):883-94
Indexing Information
Protein Kinase Inhibitors
Date of Entry
2010/07/05
Revision Date
2013/10/24
N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide Preferred
PF 03814735 Narrower
page delivered in 0.005s